Skip to content
MedsAcross

Medicine

Amlodipine and Atorvastatin 2.5 mg/20 mg tablet

Available on requestPrescription onlyUS FDAGeneric name

Amlodipine and Atorvastatin 2.5 mg/20 mg tablet is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 25°C (77°F), excursions permitted to 15°C –30°C (59°F –86°F).

Key facts

Active ingredient (INN)
Amlodipine and Atorvastatin
Brand
Sold under the generic name
Strength
2.5 mg/20 mg
Dosage form
Tablet
Route
Oral
Packs
30 tablets, 90 tablets, 500 tablets and 6 more
Manufacturers
Alembic PharmaceuticalsIndiaDr. Reddy's LaboratoriesIndiaPrasco Laboratories
Origin register
US FDA, United States
Storage
Store at 25°C (77°F), excursions permitted to 15°C –30°C (59°F –86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
C10BX03 Amlodipine and Atorvastatin
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
17 March 2014
Identifiers
RxCUI 404011, 404013, 597967 +7DailyMed set ID 14124e56-77ba-426d-8f5a-dbe42eda1a20, 1346631f-e6db-4c5c-a6af-5aa7b80a011d, abee4a34-89cc-d886-192c-32582ab8f024 +1NDC 66993-264, 62332-756, 43598-320 +1Application NDA021540, ANDA217279, ANDA203874

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
30 tablet, film coated in 1 bottle46708-756-30Alembic PharmaceuticalsIndia23 May 2025
90 tablet, film coated in 1 bottle46708-756-90Alembic PharmaceuticalsIndia23 May 2025
30 tablet, film coated in 1 bottle62332-756-30Alembic PharmaceuticalsIndia23 May 2025
90 tablet, film coated in 1 bottle62332-756-90Alembic PharmaceuticalsIndia23 May 2025
500 tablet, film coated in 1 bottle43598-320-05Dr. Reddy's LaboratoriesIndia17 March 2014
30 tablet, film coated in 1 bottle43598-320-30Dr. Reddy's LaboratoriesIndia17 March 2014
60 tablet, film coated in 1 bottle43598-320-60Dr. Reddy's LaboratoriesIndia17 March 2014
90 tablet, film coated in 1 bottle43598-320-90Dr. Reddy's LaboratoriesIndia17 March 2014
30 tablet, coated in 1 bottle66993-264-30Prasco Laboratories14 March 2022

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 30 January 2004Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Amlodipine and Atorvastatin

Clinical summary

Amlodipine and Atorvastatin is a fixed-dose combination of a dihydropyridine calcium channel blocker, an HMG-CoA reductase inhibitor and a calcium channel blocker indicated in patients for whom treatment with both amlodipine and atorvastatin is appropriate. MedsAcross supplies Amlodipine and Atorvastatin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Amlodipine and Atorvastatin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Amlodipine and Atorvastatin 2.5 mg/20 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.